Ignite Creation Date:
2025-12-24 @ 3:28 PM
Ignite Modification Date:
2025-12-27 @ 3:29 AM
Study NCT ID:
NCT00121992
Status:
COMPLETED
Last Update Posted:
2023-04-04
First Post:
2005-07-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Docetaxel, Doxorubicin (A), Cyclophosphamide (C) (TAC) vs 5-Fluorouracil, A, C (5FAC) Breast Cancer Adjuvant Treatment
Sponsor:
Spanish Breast Cancer Research Group
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
1999-07
Start Date Type:
ACTUAL
Primary Completion Date:
2010-12-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-03-06
Completion Date Type:
ACTUAL
First Submit Date:
2005-07-18
First Submit QC Date:
None
Study First Post Date:
2005-07-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-10-13
Results First Submit QC Date:
None
Results First Post Date:
2020-12-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-03
Last Update Post Date:
2023-04-04
Last Update Post Date Type:
ACTUAL